Evaluation of Main Determinants of Postprandial Glucose Response in Type 1 Diabetes
IN-DEEP
Evaluation of the INteraction Between Diet, microbiomE and Epigenetic Towards Personalized Interventions in Type 1 Diabetes (IN-DEEP Study)
1 other identifier
observational
200
1 country
1
Brief Summary
The goal of this observational study is to explore inter- and intra-individual determinants of postprandial glucose response in patients with type 1 diabetes using continous glucose monitoring (CGM). Blood samples and anthropometrics will be collected during hospital visit. Participants will be asked to:
- record a seven-day food diary
- complete EPIC food frequency questionnaire
- complete questionnaires on sleep hygiene
- collect a stool sample
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 18, 2021
CompletedFirst Submitted
Initial submission to the registry
June 30, 2023
CompletedFirst Posted
Study publicly available on registry
July 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
September 19, 2025
October 1, 2024
6.1 years
June 30, 2023
September 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postprandial glucose response
Postprandial glucose response wil be calculated by the trapezoidal method as the area under the curve above the baseline value (iAUC). The association between iAUC and gut microbiota composition derived from the analysis of faeces samples will be assessed. The association between iAUC and energy intake and dietary composition derived from the analysis of 7-days food record and EPIC will be assessed.
Related to 7-days food record
Eligibility Criteria
The study population will consist of individuals with type 1 diabetes using continuous glucose monitoring (CGM) and regularly attending the Diabetes Outpatient Clinic of Federico II University Teaching Hospital (Naples, Italy).
You may qualify if:
- Type 1 Diabetes
You may not qualify if:
- Pregnancy and/or breastfeeding
- Other chronic or acute diseases
- Use of antibiotics in the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federico II University Hospital
Naples, 80131, Italy
Related Publications (2)
Abuqwider J, Pasolli E, Scida G, Corrado A, Vitale M, De Filippis F, Ercolini D, Annuzzi G, Rivellese AA, Bozzetto L. Gut microbiome profiles and associated functional pathways are linked to Mediterranean diet adherence and blood glucose control in adults with type 1 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2025 Dec 2:104487. doi: 10.1016/j.numecd.2025.104487. Online ahead of print.
PMID: 41484024DERIVEDAbuqwider J, Salamone D, Scida G, Corrado A, Costabile G, Luongo D, Annuzzi G, Rivellese A, Bozzetto L. Sex-specific associations of serum short-chain fatty acids with glycaemic control: an Italian cross-sectional study in adults with type 1 diabetes. BMJ Open. 2025 Mar 24;15(3):e096994. doi: 10.1136/bmjopen-2024-096994.
PMID: 40132856DERIVED
Biospecimen
whole blood, buffy coat, feces, serum, and plasma
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Medical Doctor
Study Record Dates
First Submitted
June 30, 2023
First Posted
July 7, 2023
Study Start
May 18, 2021
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
September 19, 2025
Record last verified: 2024-10